DexCom Inc
(NAS:DXCM)
$
80.47
1.06 (1.33%)
Market Cap: 31.02 Bil
Enterprise Value: 30.73 Bil
PE Ratio: 47.55
PB Ratio: 15.66
GF Score: 81/100 Dexcom Inc at Wells Fargo Healthcare Conference Transcript
Sep 06, 2023 / 07:45PM GMT
Release Date Price:
$106.88
(+6.53%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good afternoon. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with DexCom. With us, we have Jereme Sylvain, the CFO. In terms of format, it's going to be a fireside chat. If anybody has a question, please raise your hand. We'll come around with the mic.
Jereme, thanks so much for being here.
Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO
Thanks for having us, Larry. Appreciate it. Yes.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So obviously, with GLP -- GLP-1 continue to be top of mind for a lot of investors. You guys put out some interesting data yesterday. I'd love to -- for people who haven't seen it, and even people who have -- I'd love to hear from you, kind of what the highlights are from that data and what
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot